Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 725, doi. 10.1007/s40264-023-01325-0
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 2023 AND VI 46 AND IP 8
Results: 11
1
2
Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 797, doi. 10.1007/s40264-023-01324-1
- By:
- Publication type:
- Article
3
Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 781, doi. 10.1007/s40264-023-01323-2
- By:
- Publication type:
- Article
4
Provision and Characterization of a Corpus for Pharmaceutical, Biomedical Named Entity Recognition for Pharmacovigilance: Evaluation of Language Registers and Training Data Sufficiency.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 765, doi. 10.1007/s40264-023-01322-3
- By:
- Publication type:
- Article
5
Hospitalisations Related to Adverse Drug Reactions in Switzerland in 2012–2019: Characteristics, In-Hospital Mortality, and Spontaneous Reporting Rate.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 753, doi. 10.1007/s40264-023-01319-y
- By:
- Publication type:
- Article
6
Correction to: Comment on: "Should Antidepressants be Avoided in Pregnancy?".
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
7
Developing an Artificial Intelligence-Guided Signal Detection in the Food and Drug Administration Adverse Event Reporting System (FAERS): A Proof-of-Concept Study Using Galcanezumab and Simulated Data.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 743, doi. 10.1007/s40264-023-01317-0
- By:
- Publication type:
- Article
8
Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 715, doi. 10.1007/s40264-023-01316-1
- By:
- Publication type:
- Article
9
Future of ChatGPT in Pharmacovigilance.
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 711, doi. 10.1007/s40264-023-01315-2
- By:
- Publication type:
- Article
10
Authors' Reply to Juergen O Kirchner's Comment on "Incidence Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project".
- Published in:
- Drug Safety, 2023, v. 46, n. 8, p. 813, doi. 10.1007/s40264-023-01311-6
- By:
- Publication type:
- Article
11
Comment on "Rates of Autoimmune Diseases in European Healthcare Databases: A Contribution of the ADVANCE Project".
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor